Taking top spot in our most read Top 10 for November was a comment piece by Brian Fiani (New York, USA), who examined the role of minimally invasive surgery in patients with spinal deformity. Rounding out the top three were the one-year data from the TOPS IDE trial and the launch of a new tube system from NuVasive. In addition, there was some highly interesting research on spinal cord burst stimulation, the use of artificial intelligence and treatment options for degenerative spondylolisthesis, as well as industry news from the likes of Globus Medical, DePuy Synthes and SeaSpine.
Brian Fiani, a neurosurgeon at Weill Cornell Medicine/NewYork-Presbyterian Hospital (New York, USA), examines some of the main benefits and also limitations associated with minimally invasive surgery (MIS) for patients who suffer from spinal deformity, as well as what the future might hold for such techniques within the field.
Premia Spine recently announced the publication of one-year outcomes from the TOPS facet replacement system’s clinical trial which found that lumbar facet arthroplasty with the TOPS device demonstrated a statistically significant improvement in all patient-reported outcome measures, a low surgical complication rate, and the ability to maintain motion at the index level while limiting sagittal translation.
NuVasive has announced the commercial launch of the NuVasive Tube System (NTS) and Excavation Micro, a new minimally invasive surgery (MIS) system that the company states provides comprehensive solutions for both transforaminal lumbar interbody fusion (TLIF) and decompression.
Among patients with chronic radicular pain after lumbar spine surgery, spinal cord burst stimulation, compared with placebo stimulation, results in no significant difference in back pain-related disability, new research has shown.
The National Health Service (NHS) and Globus Medical have partnered to provide state-of-the-art robotic navigation technology for spinal surgery to NHS hospitals across the UK.
Augmented reality (AR) has the ability to improve the surgical workflow during minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) procedures, new research, published in the journal Neurospine by Roger Härtl (New York-Presbyterian Hospital, New York, USA) et al, suggests.
Degenerative cervical spine patients who are aware of their preoperative scores demonstrate better patient-reported outcome measures (PROMs) than those who do not, new research has found.
There is little consensus on the treatment of degenerative spondylolisthesis (DS) among members of both the Lumbar Spine Research Society and Society of Minimally Invasive Spine Surgery, according to new research, which also highlighted a substantial variation in treatment patterns, despite the majority of members utilising fusion.
DePuy Synthes, the orthopaedics company of Johnson & Johnson, has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its TELIGEN system, an integrated technology platform that enables minimally invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures through digital tools for visualisation and access.
SeaSpine has announced the full commercial launch of the Mariner MIS Wayfinder system, a novel, one step, k-wireless screw delivery system for pedicle screw fixation.